Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FOCINVEZ safely and effectively. See full prescribing information for FOCINVEZ. FOCINVEZ (fosaprepitant injection) for intravenous useInitial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
FOCINVEZ, in combination with other antiemetic agents, is indicated in adults and pediatric patients 6 months of age and older for the prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). Limitations of Use FOCINVEZ has not been studied for the treatment of established nausea and vomiting.
- generic_name
- fosaprepitant dimeglumine
- product_names
- FOSAPREPITANT DIMEGLUMINE
- ndc
- 70121-2631, 70121-2631-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en